Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

por Klomp, M.J., Dalm, S.U., de Jong, M., Feelders, R.A., Hofland, J., Hofland, L.J.
Publicado 2020

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

por Varewijck, A. J., Janssen, J. A. M. J. L., Vähätalo, M., Hofland, L. J., Lamberts, S. W. J., Yki-Järvinen, H.
Publicado 2012

The role of superoxide anions in the development of distant tumour recurrence

por ten Kate, M, van der Wal, J B C, Sluiter, W, Hofland, L J, Jeekel, J, Sonneveld, P, van Eijck, C H J
Publicado 2006

In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life

por Varewijck, A J, van der Lely, A J, Neggers, S J C M M, Lamberts, S W J, Hofland, L J, Janssen, J A M J L
Publicado 2014

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors

por van Adrichem, R C S, Hofland, L J, Feelders, R A, De Martino, M C, van Koetsveld, P M, van Eijck, C H J, de Krijger, R R, Sprij-Mooij, D M, Janssen, J A M J L, de Herder, W W
Publicado 2013